ArticleBiomedicines2023
Detection of Liver Tumour Using Deep Learning Based Segmentation with Coot Extreme Learning Model.
Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A comparison of contrast-to-noise ratio of liver tumors between dynamic contrast-enhanced CT and respiration-tracked 4D-CT for radiotherapy targeting.The British journal of radiology · 2026Article
- A Systematic Review of Deep Learning Approaches for Hepatopancreatic Tumor Segmentation.Journal of imaging · 2026Review
- Preliminary study on detection and diagnosis of focal liver lesions based on a deep learning model using multimodal PET/CT images.European journal of radiology open · 2025Article
- Liver Tumor Prediction using Attention-Guided Convolutional Neural Networks and Genomic Feature Analysis.MethodsX · 2025Article
- Liver margin segmentation in abdominal CT images using U-Net and Detectron2: annotated dataset for deep learning models.Scientific reports · 2025Article
- A Multi-Scale Liver Tumor Segmentation Method Based on Residual and Hybrid Attention Enhanced Network with Contextual Integration.Sensors (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systems for medical analytics and decision making that make use of multimodal intelligence are of critical importance in the field of healthcare. Liver cancer is one of the most frequent types of cancer and early identification of it is crucial for effective therapy. Liver tumours share the same brightness and contrast characteristics as their surrounding tissues. Likewise, irregular tumour shapes are a serious concern that varies with cancer stage and tumour kind. There are two main phases of tumour segmentation in the liver: identifying the liver, and then segmenting the tumour itself. Conventional interactive segmentation approaches, however, necessitate a high number of intensity levels, whereas recently projected CNN-based interactive segmentation approaches are constrained by low presentation on liver tumour images. This research provides a unique deep Learning based Segmentation with Coot Extreme Learning Model approach that shows high efficiency in results and also detects tumours from the publicly available data of liver images. Specifically, the study processes the initial segmentation with a small number of additional users clicks to generate an improved segmentation by incorporating inner boundary points through the proposed geodesic distance encoding method. Finally, classification is carried out using an Extreme Learning Model, with the classifier's parameters having been ideally chosen by means of the Coot Optimization algorithm (COA). On the 3D-IRCADb1 dataset, the research evaluates the segmentation quality metrics DICE and accuracy, finding improvements over approaches in together liver-coloured and tumour separation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.